China Universal Asset Management Company’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.6K | Buy |
11,195
+40
| +0.4% | +$188 | 0.01% | 417 |
|
|
2025
Q1 | $40.7K | Sell |
11,155
-633
| -5% | -$2.31K | ﹤0.01% | 430 |
|
|
2024
Q4 | $55.6K | Buy |
+11,788
| New | +$55.6K | 0.01% | 445 |
|
|
2023
Q4 | – | Sell |
-1,073
| Closed | -$5.37K | – | 448 |
|
|
2023
Q3 | $5.37K | Buy |
1,073
+525
| +96% | +$2.63K | ﹤0.01% | 383 |
|
|
2023
Q2 | $3.86K | Sell |
548
-18
| -3% | -$127 | ﹤0.01% | 392 |
|
|
2023
Q1 | $3.51K | Buy |
566
+141
| +33% | +$874 | ﹤0.01% | 403 |
|
|
2022
Q4 | $2.71K | Buy |
+425
| New | +$2.71K | ﹤0.01% | 354 |
|